相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
Adrienne D. Cox et al.
CLINICAL CANCER RESEARCH (2015)
Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding
Pamela Y. Ting et al.
FASEB JOURNAL (2015)
Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region
Hyunbum Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations
Dean E. Hammond et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations
John C. Hunter et al.
MOLECULAR CANCER RESEARCH (2015)
The Ras-Membrane Interface: Isoform-Specific Differences in the Catalytic Domain
Jillian A. Parker et al.
MOLECULAR CANCER RESEARCH (2015)
Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer
Jamie D. Weyandt et al.
PLOS ONE (2015)
K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif
Frederick D. Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD
Susan K. Fetics et al.
STRUCTURE (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Precision medicine in colorectal cancer: the molecular profile alters treatment strategies
Nguyen H. Tran et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
The Differential Palmitoylation States of N-Ras and H-Ras Determine Their Distinct Golgi Subcompartment Localizations
Stephen J. Lynch et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Rare codons capacitate Kras-driven de novo tumorigenesis
Nicole L. K. Pershing et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The mutational landscapes of genetic and chemical models of Kras-driven lung cancer
Peter M. K. Westcott et al.
NATURE (2015)
Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo
Wanglong Qiu et al.
Oncotarget (2015)
Modeling the Role of G12V and G13V Ras Mutations in the Ras-GAP-Catalyzed Hydrolysis Reaction of Guanosine Triphosphate
Maria G. Khrenova et al.
BIOCHEMISTRY (2014)
Wild-Type H- and N-Ras Promote Mutant K-Ras-Driven Tumorigenesis by Modulating the DNA Damage Response
Elda Grabocka et al.
CANCER CELL (2014)
Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
Carles Barcelo et al.
CANCER RESEARCH (2014)
Dynamics of KRas on endosomes: involvement of acidic phospholipids in its association
Mariona Gelabert-Baldrich et al.
FASEB JOURNAL (2014)
Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
Chad V. Pecot et al.
MOLECULAR CANCER THERAPEUTICS (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Small RNA combination therapy for lung cancer
Wen Xue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation
Severa Bunda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C
John C. Hunter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
KRAS: feeding pancreatic cancer proliferation
Kirsten L. Bryant et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Development of siRNA Payloads to Target KRAS-Mutant Cancer
Tina L. Yuan et al.
CANCER DISCOVERY (2014)
Mutation-Specific RAS Oncogenicity Explains NRAS Codon 61 Selection in Melanoma
Christin E. Burd et al.
CANCER DISCOVERY (2014)
Rare Codons Regulate KRas Oncogenesis
Benjamin L. Lampson et al.
CURRENT BIOLOGY (2013)
Differences in the Regulation of K-Ras and H-Ras Isoforms by Monoubiquitination
Rachael Baker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
Takeshi Ogura et al.
JOURNAL OF GASTROENTEROLOGY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling
Gunther Zimmermann et al.
NATURE (2013)
US National Cancer Institute's new Ras project targets an old foe
Helen Thompson
NATURE MEDICINE (2013)
Site-specific monoubiquitination activates Ras by impeding GTPase-activating protein function
Rachael Baker et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis
M. D. To et al.
ONCOGENE (2013)
In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction
Fumi Shima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
NMR-based functional profiling of RASopathies and oncogenic RAS mutations
Matthew J. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Oncogenic and Wild-type Ras Play Divergent Roles in the Regulation of Mitogen-Activated Protein Kinase Signaling
Amy Young et al.
CANCER DISCOVERY (2013)
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation
Qi Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
Madhu S. Kumar et al.
CELL (2012)
Association of KRAS G13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab
Sabine Tejpar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Nathan T. Ihle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Regulating the regulator: post-translational modification of RAS
Ian M. Ahearn et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Regulation of RAS oncogenicity by acetylation
Moon Hee Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
Till Maurer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Analysis of Binding Site Hot Spots on the Surface of Ras GTPase
Greg Buhrman et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Raft Protein Clustering Alters N-Ras Membrane Interactions and Activation Pattern
Sharon Eisenberg et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Ubiquitination of K-Ras Enhances Activation and Facilitates Binding to Select Downstream Effectors
Atsuo T. Sasaki et al.
SCIENCE SIGNALING (2011)
Ras membrane orientation and nanodomain localization generate isoform diversity
Daniel Abankwa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Dominico Vigil et al.
NATURE REVIEWS CANCER (2010)
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
Claudia Scholl et al.
CELL (2009)
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Ji Luo et al.
CELL (2009)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Mechanisms of Ras membrane organization and signaling: Ras on a rocker
Daniel Abankwa et al.
CELL CYCLE (2008)
Tumour maintenance is mediated by eNOS
Kian-Huat Lim et al.
NATURE (2008)
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
Kevin M. Haigis et al.
NATURE GENETICS (2008)
Transformation efficiency of RasQ61 mutants linked to structural features of the switch regions in the presence of Raf
Greg Buhrman et al.
STRUCTURE (2007)
Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells
Aparna V. Sarthy et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Differential modification of Ras proteins by ubiquitination
N Jura et al.
MOLECULAR CELL (2006)
Recognizing and defining true Ras binding domains II:: In silico prediction based on homology modelling and energy calculations
C Kiel et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Recognizing and defining true Ras binding domains 1:: Biochemical analysis
S Wohlgemuth et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Three separable domains regulate GTP-dependent association of H-ras with the plasma membrane
B Rotblat et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Wildtype Kras2 can inhibit lung carcinogenesis in mice
ZQ Zhang et al.
NATURE GENETICS (2001)
分享论文
